Individualized homeopathic medicines in upper respiratory tract infections in children: Double-blind, randomized, placebo-controlled pilot trial

D N De Homoeopathic Medical College Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Clinical signs and symptoms of an upper respiratory tract infections with a duration of greater than or equal to 24 hours with or without fever greater than or equal to 37.5 degree Celsius.
•2. At least 1 of 3 types of upper respiratory tract infections symptoms Ã¢â?¬â?? nasal (plugged nose, runny nose, sneezing), pharyngeal (scratchy throat, sore throat, pharyngeal hyperemia),
•and cough (ordinary cough without suspicion of acute lower respiratory tract disease).
•3. At least 1 of 5 general symptoms Ã¢â?¬â?? feeling tired, weakness, body ache, irritable or whiney, or less active.
•4. Literate guardians or attendants capable of understanding and filling the questionnaire and providing written informed consent.

•1. Severe or complicated course of upper respiratory tract infections.
•2. Signs of acute lower respiratory tract infections.
•3. COVID-19 positive cases.
•4. Current symptoms mainly induced by other acute ear, nose, throat diseases.
•5. Daily use of antibiotics, steroids and cytotoxic agents.
•6. Immune-compromised state.
•8. Already undergoing homeopathic or other modes of treatment for upper respiratory tract infections.

发起方